Expression of thymidylate synthase in human gastric and colorectal adenocarcinomas is upregulated by p16/INK4

被引:0
|
作者
Omura, K [1 ]
Uno, Y [1 ]
Kawakami, K [1 ]
Kanehira, E [1 ]
Tawaraya, K [1 ]
Tsukayama, M [1 ]
Hiranuma, C [1 ]
Watanabe, Y [1 ]
机构
[1] Kanazawa Univ, Sch Med, Fac Med, Dept Surg 1, Kanazawa, Ishikawa 9208641, Japan
关键词
thymidylate synthase; G1; checkpoint; cell cycle regulator; gastric carcinoma; colorectal carcinoma;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: We observed the relationship between the expression of thymidylate synthase protein (pTS) and cell cycle regulators in gastric and colorectal adenocarcinoma tissues. Methodology: This study included 80 gastric and 50 colorectal adenocarcinomas. Immunohistochemical staining was performed using a polyclonal antibody to recombinant human pTS, and monoclonal antibodies to p53, p21/WAF1CIP1, p16/INK4, cyclin D1 and pRB. Each staining was quantified using computerized image analysis on a CAS 200 system. We selected the mean expression values as the cutoff values to distinguish between high and low expression of these substances. Results: There was no relationship between pTS expression and p21/WAF1CIP1, cyclin D1, or pRB expression in gastric and colorectal carcinomas. In both gastric and colorectal carcinomas, the pTS expression was significantly low in the high p16m/INK4 expression subgroup compared with the low p16/INK4 expression subgroup (P<0.05). Further, the pTS expression was significantly high in the high p53 expression subgroup compared with the low p53 expression subgroup in colorectal adenocarcinomas (P<0.05). Conclusions: pTS expression regulation in human gastric and colorectal adenocarcinomas is complex, and upregulated by p16/INK4.
引用
收藏
页码:742 / 745
页数:4
相关论文
共 50 条
  • [1] MUTATIONS AND ALTERED EXPRESSION OF P16(INK4) IN HUMAN CANCER
    OKAMOTO, A
    DEMETRICK, DJ
    SPILLARE, EA
    HAGIWARA, K
    HUSSAIN, SP
    BENNETT, WP
    FORRESTER, K
    GERWIN, B
    SERRANO, M
    BEACH, DH
    HARRIS, CC
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (23) : 11045 - 11049
  • [2] P16(INK4 alpha) promoter is hypermethylated at a high frequency in esophageal adenocarcinomas
    Wong, DJ
    Barrett, MT
    Stoger, R
    Emond, MJ
    Reid, BJ
    CANCER RESEARCH, 1997, 57 (13) : 2619 - 2622
  • [3] Inactivation of p16(INK4) in hepatocellular carcinoma
    Hui, AM
    Sakamoto, M
    Kanai, Y
    Ino, Y
    Gotoh, M
    Yokota, J
    Hirohashi, S
    HEPATOLOGY, 1996, 24 (03) : 575 - 579
  • [4] Absence of deletions but frequent loss of expression of p16(INK4) in human ovarian tumours
    Marchini, S
    Codegoni, AM
    Bonazzi, C
    Chiari, S
    Broggini, M
    BRITISH JOURNAL OF CANCER, 1997, 76 (02) : 146 - 149
  • [5] P16(INK4) MUTATIONS AND ALTERED EXPRESSION IN HUMAN TUMORS AND CELL-LINES
    OKAMOTO, A
    DEMETRICK, DJ
    SPILLARE, EA
    HAGIWARA, K
    HUSSAIN, SP
    BENNETT, WP
    FORRESTER, K
    GERWIN, B
    GREENBLATT, MS
    SERRANO, M
    SHISEKI, M
    YOKOTA, J
    BEACH, DH
    HARRIS, CC
    COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1994, 59 : 49 - 57
  • [6] ANALYSIS OF P16(INK4) GENE IN RHABDOMYOSARCOMA
    IOLASCON, A
    FAIENZA, MF
    COPPOLA, B
    BASSO, G
    ROSOLEN, A
    SCHETTINI, F
    PEDIATRIC RESEARCH, 1995, 38 (03) : 438 - 438
  • [7] Infrequent mutation of p16(INK4) in sporadic melanoma
    Healy, E
    Sikkink, S
    Rees, JL
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 107 (03) : 318 - 321
  • [8] Association of extended in vitro proliferative potential with loss of p16(INK4) expression
    Noble, JR
    Rogan, EM
    Neumann, AA
    Maclean, K
    Bryan, TM
    Reddel, RR
    ONCOGENE, 1996, 13 (06) : 1259 - 1268
  • [9] LOSS OF P16(INK4) EXPRESSION IS FREQUENT IN HIGH-GRADE GLIOMAS
    NISHIKAWA, R
    FURNARI, FB
    LIN, H
    ARAP, W
    BERGER, MS
    CAVENEE, WK
    HUANG, HJS
    CANCER RESEARCH, 1995, 55 (09) : 1941 - 1945
  • [10] Deletions and rearrangements inactivate the p16(INK4) gene in human glioma cells
    Srivenugopal, KS
    AliOsman, F
    ONCOGENE, 1996, 12 (09) : 2029 - 2034